The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ESOPEC: A prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy to neoadjuvant chemoradiation in patients with adenocarcinoma of the esophagus (NCT02509286).
 
Jens Hoeppner
Travel, Accommodations, Expenses - Celgene
 
Florian Lordick
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Nordic Group; Roche Pharma AG
Consulting or Advisory Role - BioNTech; GANYMED Pharmaceuticals; Roche (Inst)
Research Funding - Boehringer Ingelheim (Inst); Fresenius Biotech; GlaxoSmithKline (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer; Roche; Taiho Pharmaceutical
 
Thomas B. Brunner
No Relationships to Disclose
 
Torben Glatz
No Relationships to Disclose
 
Claudia Schmoor
No Relationships to Disclose
 
Dietmar Lorenz
No Relationships to Disclose
 
Christian Ell
No Relationships to Disclose
 
Joerg Ruediger Siewert
No Relationships to Disclose
 
Ulrich Theodor Hopt
No Relationships to Disclose